DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING AN INORGANIC SALT Russian patent published in 2016 - IPC A61K9/16 A61K9/20 A61K47/02 

Abstract RU 2604676 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to pharmaceutics, namely to a pharmaceutical dosage form with breaking strength of at least 500 N, mentioned dosage form contains pharmacologically active component (A); inorganic salt (B), where inorganic salt (B) is sodium carbonate or five-substituted sodium triphosphate or mixture of them, and content of inorganic salt (B) ranges from 15 to 40 wt%, based on total weight of dosage form; and polyalkylene oxide (C), having weight-average molecular weight of at least 200.000 g/mol, where content of polyalkylene oxide (C) is at least 30 wt% of total weight of dosage form; where pharmacologically active component (A) is present in controlled-release matrix containing inorganic salt (B) and polyalkylene oxide (C) and where in vitro, release profile of pharmacologically active component (A) from mentioned matrix includes at least, time interval during which release corresponds to zero-order kinetics.

EFFECT: stated pharmaceutical dosage form is suitable for avoiding abuse of pharmacologically active component, which is contained in it.

10 cl, 3 ex, 5 dwg

Similar patents RU2604676C2

Title Year Author Number
DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING ANIONIC POLYMER 2011
  • Barnshajd Lutts Dr.
  • Shvir Zebastian Dr.
  • Bartolomojs Iogannes Dr.
RU2607499C2
DRUG FORM 2009
  • Jan Ehzhen Mari Zhozef
  • Keken Filip Rene Irena
  • Vorspuls Zhodi Firmin Marseline
  • Fore Anne
  • Arkenau-Marik Ehlizabet
  • Barnshajd Lutts
  • Bartolomojs Iogannes
  • Frevel' Mark
  • Galia Ehrik
  • Tsigler Iris
  • Shjussele Andrea
RU2493830C2
MISUSE PROTECTED DOSAGE FORM FOR OXIDATION SENSITIVE OPIOIDS 2010
  • Iogannes Bartolomehus
  • Anja Gajssler
  • Ul'Rike Bertram
  • Kornelija Grissmann
RU2555531C2
OXIDATION STABLE AND BREAKING RESISTANCE DOSAGE FORM 2010
  • Lutts Barnshajd
  • Ehrik Galija
  • Zebastian Shvir
  • Ul'Rike Bertram
  • Anja Gajssler
  • Kornelija Grissmann
  • Iogannes Bartolomehus
RU2567723C2
HOT-MELT EXTRUDED PHARMACEUTICAL DOSAGE FORM 2010
  • Lutts Barnshajd
  • Ehrik Galija
RU2547555C2
PERORAL SOLID DOSAGE FORM WITH MYCOPHENOLIC ACID OR ITS SALT FOR USE AS AN IMMUNODEPRESSANT FOR TREATMENT OR PREVENTION OF ORGAN OR TISSUE TRANSPLANT REJECTION AND METHOD FOR PRODUCTION THEREOF 2016
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2670447C2
PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR 2006
  • Vasantavada Madkhav
  • Lakshman Dzhej Partiban
  • Ton Vehjtsin'
  • Seradzhuddin Abu T.M.
RU2404775C2
PHARMACEUTICAL COMPOSITION 2018
  • Geissler Simon
  • Jeschke Martina
  • Boniforte Patrizia
  • Weigandt Markus
RU2809144C2
EXTRUDATE WITH SODIUM MYCOPHENOLATE TO PRODUCE PERORAL SOLID DOSAGE FORM 2018
  • Khazanova Elena Sergeevna
  • Nogaj Sergej Yurevich
  • Filippova Evgeniya Aleksandrovna
RU2723255C2
DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL- OR N, N-DIMETHYL-)-4-PHENYL-4', 9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE 2011
  • Shiller Mark
  • Gryuning Nadya
  • Khemani Ashish
RU2589831C2

RU 2 604 676 C2

Authors

Barnshajd Lutts

Dates

2016-12-10Published

2011-09-01Filed